Compared with the healthy control group, BTD expression was approximately 71% lower and EIF4E expression was approximately 25% lower in the PD group, and the expression levels were positively correlated with lnc‐MKRN2‐42:1 (Figure 4). This evidence concerns the gene BTD and Parkinson disease.